The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Glycemic Control and Coronary Heart Disease Risk in Persons With and Without Diabetes: The Atherosclerosis Risk in Communities Study
Abstract
BACKGROUND: Chronic hyperglycemia has been hypothesized to contribute to coronary heart disease (CHD), but the extent to which hemoglobin A(1c) (HbA(1c)) level, a marker of long-term glycemic control, is independently related to CHD risk is uncertain. METHODS: We conducted a prospective case-cohort study of 1321 adults without diabetes and a cohort study of 1626 adults with diabetes from the Atherosclerosis Risk in Communities Study. Using proportional hazards models, we assessed the relation between HbA(1c) level and incident CHD during 8 to 10 years of follow-up. RESULTS: In adults with diabetes, the relative risk (RR) of CHD was 2.37 (95% confidence interval [CI], 1.50-3.72) for the highest quintile of HbA(1c) level compared with the lowest after adjustment for CHD risk factors. In persons without diabetes, the adjusted RR of CHD in the highest quintile of HbA(1c) level was 1.41 (95% CI, 0.90-2.30); however, there was evidence of a nonlinear relationship in this group. In nondiabetic adults, HbA(1c) level was not related to CHD risk below a level of 4.6% but was significantly related to risk above that level (P<.001). In diabetic adults, the risk of CHD increased throughout the range of HbA(1c) levels. In the adjusted model, the RR of CHD for a 1-percentage point increase in HbA(1c) level was 2.36 (95% CI, 1.43-3.90) in persons without diabetes but with an HbA(1c) level greater than 4.6%. In diabetic adults, the RR was 1.14 (95% CI, 1.07-1.21) per 1-percentage point increase in HbA(1c) across the full range of HbA(1c) values. CONCLUSION: Elevated HbA(1c) level is an independent risk factor for CHD in persons with and without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“In a prospective analysis of data from the UKPDS, the authors showed that updated mean HbA1c level was more strongly related to increased risk of MI compared with baseline HbA1c level.(8) This suggests that the present study is likely to have underestimated any true association between HbA1c level and CHD.”
MethodStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945
(1989) · PubMed · Cited by 3,139
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Coutinho, M., Gerstein, H. C., Wang, Y., & Yusuf, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.233 · Cited by 1,685
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N. R., & Golden, S. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00007 · Cited by 1,657
Self-citationKhaw, K.-T. (2001) · BMJ · doi:10.1136/bmj.322.7277.15 · Cited by 1,017
Khaw, K.-T., Wareham, N., Bingham, S., Luben, R., Welch, A., & Day, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00006 · Cited by 974
Siedel, J., Hägele, E. O., Ziegenhorn, J., & Wahlefeld, A. W. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.6.1075 · Cited by 942
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
Shichiri, M., Kishikawa, H., Ohkubo, Y., & Wake, N. (2000) · PubMed · Cited by 727
White, A. D., Folsom, A. R., Chambless, L. E., Sharret, A. R., Yang, K., Conwill, D., Higgins, M., Williams, O. D., Tyroler, H. A., & The ARIC Investigators (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00041-0 · Cited by 688
Self-citationBalkau, B., Shipley, M., Jarrett, R. J., Pyörälä, K., Pyörälä, M., Forhan, A., & Eschwège, E. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.360 · Cited by 598
Pickup, J. C., & Williams, G. H. (1991) · Cited by 571
Robust Variance Estimation for the Case-Cohort Design
Barlow, W. E. (1994) · Biometrics · doi:10.2307/2533444 · Cited by 540
The DECODE Study Group, & on behalf of the European Diabetes Epidemiology Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.688 · Cited by 516
Likelihood Ratio Tests in Linear Mixed Models with One Variance Component
Crainiceanu, C. M., & Ruppert, D. (2004) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2004.00438.x · Cited by 445
Adler, A. I., Stevens, R. J., Neil, A., Stratton, I. M., Boulton, A. J. M., Holman, R. R., & for the U.K. Prospective Diabetes Study Group (2002) · Diabetes Care · doi:10.2337/diacare.25.5.894 · Cited by 429
Kothari (2002) · doi:10.1161/01.str.0000020091.07144.c7 · Cited by 420
Jackson, R., Chambless, L. E., Yang, K., Byrne, T., Watson, R., Folsom, A., Shahar, E., & Kalsbeek, W. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00047-x · Cited by 332
Self-citationNägele, U., Hägele, E. O., Sauer, G., Wiedemann, E., Lehmann, P., Wahlefeld, A. W., & Gruber, W. (1984) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.1984.22.2.165 · Cited by 313
Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes
Stevens, R. J., Coleman, R. L., Adler, A. I., Stratton, I. M., Matthews, D. R., & Holman, R. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.201 · Cited by 295
Park, S., Barrett-Connor, E., Wingard, D. L., Shan, J., & Edelstein, S. (1996) · Diabetes Care · doi:10.2337/diacare.19.5.450 · Cited by 161 · cited 1×
“In persons without diabetes, several recent studies have shown that HbA1c level predicts cardiovascular disease events prospectively and atherosclerosis cross-sectionally, independent of known risk factors.(16-21) However, previous studies have not rigorously examined the association between HbA1c level and CHD risk s…”
ResultGlucose metabolism and coronary heart disease in patients with normal glucose tolerance
Sasso, F. C. (2004) · JAMA · doi:10.1001/jama.291.15.1857 · Cited by 117
Adler, A., Neil, H. A. W., Manley, S. E., Holman, R. R., & Turner, R. C. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70035-9 · Cited by 97
Hemoglobin A1c Level and Future Cardiovascular Events Among Women
Blake, G. J., Pradhan, A. D., Manson, J. E., Williams, G. R., Buring, J. E., Ridker, P. M., & Glynn, R. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.7.757 · Cited by 92
Tracking of glycated hemoglobin in the original cohort of the framingham heart study
Meigs, J. B., Nathan, D. M., Cupples, L. A., Wilson, P. W. F., & Singer, D. E. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00513-7 · Cited by 85
Jørgensen, L., Jenssen, T. G., Joakimsen, O., Heuch, I., Ingebretsen, O. C., & Jacobsen, B. K. (2004) · Circulation · doi:10.1161/01.cir.0000136809.55141.3b · Cited by 76
Vitelli, L. L., Shahar, E., HEISS, G. M., McGovern, P. G., Brancati, F. L., Eckfeldt, J. H., Folsom, A. R., & Atherosclerosis risk in Communities (ARIC) Study Investigators (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1454 · Cited by 72
Self-citation
Cited by
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Self-citationNathan, D. M., Buse, J. B., Davidson, M. B., Heine, R. J., Holman, R. R., Sherwin, R., & Zinman, B. (2006) · Diabetes Care · doi:10.2337/dc06-9912 · Cited by 1,203
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
Long-term effects of intensive glucose lowering on cardiovascular outcomes
The ACCORD Study Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006524 · Cited by 1,035
Metadata
- Authors
- Selvin, E., Coresh, J., Golden, S. H., Brancati, F. L., Folsom, A. R., & Steffes, M. W.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2005-09-12
- Volume
- 165
- Issue
- 16
- Pages
- 1910
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2168205528
- Cited by
- 289
- References
- 33
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.